Recruiting PHASE2 INTERVENTIONAL 1-arm NCT06342466

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

A Study of Bortezomib, Pomalidomide, Dexamethasone in Patients with Systemic AL Amyloidosis

Sponsor: Jin Lu, MD

Interventions Bortezomib Dexamethasone Pomalidomide

Updated 5 times since 2024 Last updated: Dec 25, 2024 Started: May 6, 2024 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Systemic Amyloidosis, this trial is actively recruiting participants. The trial is conducted by Jin Lu, MD and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Recruiting PHASE2
Sep 2024 — Feb 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE2
May 2024 — Jun 2024 [monthly]

Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jin Lu, MD

Data source: Peking University People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China